CytoDyn Revenue, Profits - CYDY Quarterly Income Statement

Add to My Stocks
$0.62 $0.01 (1.59%) CYDY stock closing price Sep 19, 2018 (Closing)

Fundamental analysis of CYDY stock involves analyzing its financial statements, apart from checking the CytoDyn stock price. An income statement is one of the three key financial statements furnished by a company, the other two being the balance sheet and the cashflow statement. When compared with the corresponding income statement from the past, the latest income statement shows how revenue has decreased from - to - and how operating and non operating activities have impacted the CYDY stock. The operating expenses as shown in the CytoDyn profit and loss statement for 2018 Q4 total to $11.11M. This line item shows that the operating expenses has decreased compared with last year. Also check: CytoDyn assets and CytoDyn free cash flow.

View and download details of revenue and profits for CytoDyn for latest & last 40 quarters.
show more
Quarterly
Annual
View Previous Quarters
View Next Quarters
Fiscal year is Jun - May2018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q3
CytoDyn Revenues or Net Sales
----------
Cost Of Goods Sold (COGS)----------
CytoDyn Gross Profit
----------
Research & Development Expense8.92M12.07M9.07M8.14M5.61M6.53M4.38M3.68M4.03M2.74M
Selling General & Admin Expense2.19M1.97M1.6M1.56M2.11M1.39M1.67M1.58M2.49M2.21M
Income Before Depreciation Depletion Amortization-11.11M-14.05M-10.68M-9.71M-7.72M-7.92M-6.06M-5.26M-6.51M-4.95M
Depreciation Depletion Amortization----------
Non Operating Income1.97M-0.74M--0.36M--0.02M1.22M---
Interest Expense-3.06M1M1.45M------
CytoDyn Pretax Income
-9.62M-17.95M-10.94M-11.62M-6.84M-8.11M-5.46M-5.35M-6.51M-5.04M
Provision for Income Taxes----------
MinorityInterest----------
Investment Gains Losses----------
Other Income----------
Income Before Extraordinaries & Disc Operations-9.62M-17.95M-10.94M-11.63M-6.83M-8.11M-5.47M-5.35M-6.5M-5.05M
Extraordinary Items & Discontinued Operations----------
CytoDyn Profit/ Loss (Net Income)
-9.62M-17.95M-10.94M-11.63M-6.83M-8.11M-5.47M-5.35M-6.5M-5.05M
Average Shares used to compute Diluted EPS257.97M178.09M-151.74M149.99M142.18M136.02M124.41M134.38M104.84M
Average Shares used to compute Basic EPS257.97M178.09M-151.74M149.99M142.18M136.02M124.41M134.38M104.84M
Income Before Nonrecurring Items-9.62M-17.95M--11.63M-6.83M-8.11M-6.69M-5.35M-6.5M-5.05M
Income from Nonrecurring Items------1.22M---
CytoDyn Earnings Per Share Basic Net
-0.04-0.10--0.08-0.05-0.06-0.04-0.04-0.05-0.05
CytoDyn Earnings Per Share Diluted Net
-0.04-0.10--0.08-0.05-0.06-0.04-0.04-0.05-0.05
EPS Diluted Before Nonrecurring Items-0.04-0.10--0.08-0.05-0.06-0.05-0.04-0.05-0.05
Preferred Dividends Acc Pd----------
Dividends Common0.000.00--------
Dividend Per Share Common0.000.000.000.000.000.000.000.000.000.00
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Quarters
View Next Quarters

It is very helpful to read a report on CytoDyn stock analysis. An investor must check the following items in an income statement:

  • Topline: A growing topline, as seen from the CytoDyn revenue chart, as isn't the case with CytoDyn indicates a sagging business. One needs to compare the QoQ topline or sales growth of CYDY stock with its peers like FENC stock and FWP stock to see if the growth compares well with what can be expected from a company in that industry.
  • Bottom line: This refers to the last line in a profit and loss statement and denotes the net profit or loss for a particular period. The figure currently stands at $-9.62M for CytoDyn for 2018 Q4. This figure is arrived at after deducting all operating expenses, interest, and taxes from revenue.

The income statement is also called the profit and loss statement. Apart from the CYDY income statement, one can check the CytoDyn historical stock prices to check how the price has moved with time.

CytoDyn Income Statement - Key Financial Ratios